AI Assistant
Blog
Pricing
Log In
Sign Up
Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
